Five Reasons That Positioning Matters in Oncology

Posted by Malik Kaman on May 6, 2016 8:00:00 AM

Many of us in the biopharmaceutical industry marvel at the tidal wave of new treatment options in oncology. This trend should only accelerate with literally hundreds of unique medicines in phase two and phase three trials across a variety of tumor types. But what are the commercial implications of this trend?

Read More